Article
Two‐stage genome‐wide association study of chronic rhinosinusitis and disease subphenotypes highlights mucosal immunity contributing to risk
3 Jan 2021
Abstract excerpt
Chronic rhinosinusitis (CRS) is a prevalent inflammatory disease that results in over $10 billion in health-care costs annually in the United States. CRS (and its most severe form, nasal polyposis [NP]) overlaps clinically with asthma and aspirin-exacerbated respiratory disease (AERD). Despite having an enormous public health impact, the underlying molecular mechanisms of CRS remain unknown. That CRS has a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
